A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Incyte Corporation
Incyte Corporation
Seagen Inc.
Treeline Biosciences, Inc.
Kyowa Kirin Co., Ltd.
SciTech Development, Inc.
Boston Immune Technologies and Therapeutics
Kymera Therapeutics, Inc.
Bio-Path Holdings, Inc.
Daiichi Sankyo
Mundipharma Research Limited
Pfizer
Karyopharm Therapeutics Inc
Genzada Pharmaceuticals USA, Inc.
Sorrento Therapeutics, Inc.
Jiangsu Simcere Pharmaceutical Co., Ltd.
4SC AG
Innate Pharma
miRagen Therapeutics, Inc.
Rhizen Pharmaceuticals SA
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Celgene
Rhizen Pharmaceuticals SA
Progen Pharmaceuticals
TetraLogic Pharmaceuticals
Morphotek
Novartis